Insider Transactions Reported by 20 Insiders of Mirati Therapeutics, Inc.

Location
San Diego, CA

There are no Buy or Sell transactions made by insiders since 11 Mar 2025

Mirati Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
EcoR1 Capital, LLC 10%+ Owner $436,569,701 18 Dec 2023
David D. Meek Chief Executive Officer, Director $8,922,112 20 Jan 2023
Laurie Stelzer Chief Financial Officer $6,038,454 09 Aug 2023
VICKIE S. REED SVP, Chief Accounting Officer $907,078 14 Jan 2022
HENRY J. FUCHS Director $617,644 20 Jan 2023
Craig A. Johnson Director 23 Jan 2024
Carol Giltner Gallagher Director 23 Jan 2024
Davis Aaron I. Director 23 Jan 2024
John B. Moriarty Chief Legal Officer 23 Jan 2024
Maria E. Martinez Director 23 Jan 2024
BRUCE L. A. CARTER Director 23 Jan 2024
Boxer Capital, LLC Other* 23 Jan 2024
CHARLES M. BAUM Founder, President, and CEO, Director 23 Jan 2024
Jamie Christensen EVP & Chief Scientific Officer 23 Jan 2024
Julie M. Cherrington Director 23 Jan 2024
Benjamin Hickey EVP, Chief Commercial Officer 23 Jan 2024
Faheem Hasnain Director 23 Jan 2024
Shalini Sharp Director 23 Jan 2024
Alan B. Sandler Chief Medical Officer 23 Jan 2024
Aaron Ondrey Chief Financial Officer 23 Jan 2024

Recent Insider Transactions by Companies or Individuals for Mirati Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.